Malaria vaccine helps many people in Africa, but money problems are a big worry
Introduction
Two reports talk about malaria vaccine in Africa. One report is about a test in Tanzania. The other report is about the vaccine in 25 countries. The vaccine helps people, but there are problems with money and climate.
Main Body
Malaria is a big problem in Africa. Many children die from it. In Tanzania, many people get sick. A new vaccine called R21 was tested in a village. The vaccine helped a lot. Cases went down by 90%. People are very happy. The vaccine is now in 25 African countries. It is the fastest vaccine rollout ever. Early results show fewer sick children. In Burkina Faso, cases went down 32%. But giving four doses to each child is hard. Money problems are a big threat. USAID closed and lost $216 million for Tanzania. No more mosquito nets. Some medicines are not available. The vaccine test is ending. The government may not have money to pay for the vaccine. Research groups also lost money. One institute lost $15 million. Scientists cannot do all their work. The world needs more money for malaria. Without money, many children will die.
Conclusion
The vaccine is a big success. But it needs money to continue. If money stops, the good results will go away. Children will get sick again.